A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
Status:
Completed
Trial end date:
2017-10-31
Target enrollment:
Participant gender:
Summary
This is a safety, efficacy and pharmacokinetics study of the fixed combination of AGN-199201
and AGN-190584 in participants with presbyopia (inability to focus on items close-up).